Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 544 participants.
Also called NCT04790370
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 544 participants
- Registry
-
NCT04790370
-
- Other papers using this trial's data
- Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Austria, France, Germany, Ireland, Netherlands, Poland, Switzerland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT04790370. Randomized; single masking; primary purpose treatment. Start 2021-08-02 (actual); primary completion 2025-07-31 (actual). Results posted on 2026-11-16.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
- Acronym
- HI-PEITHO
- Condition
- Pulmonary Embolism
- Intervention (Drug)
- Anticoagulation with heparin
- Intervention (Device)
- EkoSonicTM Endovascular System
- Lead sponsor
- Boston Scientific Corporation
- Collaborator
- National PERT Consortium, Inc.
- Collaborator
- University Medical Center Mainz
Record details
- Record id
cardio:ct-nct04790370- Content hash
b051cc93898d29e3c7b5da7c44fde7cc8b545493c424d6aee35b73015dcc4fac